• IM Cannabis Corp IMCC reported a quarterly adjusted loss of 22 cents​​ per share for the quarter ended December 31, higher than the same quarter last year, when the company reported EPS of C$-1.50. The lone analyst forecast for the quarter was for a loss of 54 cents per share.

• Revenue rose 24.6% to C$13.34 million from a year ago; analysts expected C$14.48 million.

• IM Cannabis Corp’s reported EPS for the quarter was a loss of 22 cents​.

• The company reported a quarterly loss of C$1.01 million.

• IM Cannabis Corp shares had fallen by 21.1% this quarter.

FORECAST CHANGES

• The mean earnings estimate of analysts was unchanged in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is “hold” and the breakdown of recommendations is no “strong buy” or “buy,” 1 “hold” and no “sell” or “strong sell.” The average consensus recommendation for the drug retailers peer group is also “hold”

This summary was machine generated from LSEG data March 31 at 01:31 p.m. UTC. ​All figures in Canadian dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)